PETALING JAYA: ACE Market-listed Kanger International Bhd has entered into a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for Covid-19 vaccine distribution in Malaysia.
Zuellig Pharma is one of the license holders authorised by the Malaysian Government to handle the distribution of vaccines.
Kanger’s executive director Steven Kuah Choon Ching (pic) said in a press release that the company is pleased to be in this MOU to facilitate the distribution of Sinopharm’s Covid-19 vaccines in Malaysia.
Did you find this article insightful?
83% readers found this article insightful